Stopping insulin injections following genetic testing in diabetes: impact on identity.
Date
2010-07Journal
Diabetic medicine : a journal of the British Diabetic AssociationType
Research Support, Non-U.S. Gov'tPublisher
WileyDOI
10.1111/j.1464-5491.2010.03022.xRights
Archived with thanks to Diabetic medicine : a journal of the British Diabetic AssociationMetadata
Show full item recordAbstract
Identification of genes causing monogenic diabetes has led to treatment change, from insulin to sulphonylureas for many previously considered insulin dependent. Changing treatment has led to improved glycaemic control and quality of life; however, the impact of a genetic diagnosis and consequent treatment change on identity has not been explored.